Bharat Biotech’s vaccine Covaxin gets expert panel’s approval for restricted use
India oi-Deepika S | Updated: Sunday, January 3, 2021, 0:06 New Delhi, Jan 02: The subject expert committee ...
India oi-Deepika S | Updated: Sunday, January 3, 2021, 0:06 New Delhi, Jan 02: The subject expert committee ...
Image Source : FILE PHOTO Expert panel recommends granting restricted emergency use approval for COVAXIN. A day after a ...
India oi-Madhuri Adnal | Published: Sunday, December 27, 2020, 14:57 Ahmedabad, Dec 27: Over 750 volunteers have been ...
AIIMS, New Delhi is a site for COVAXIN Phase III clinical trial. (Representational)New Delhi: The Indian Council of Medical ...
Altogether, the data of human trials on 26,000 volunteers has to be submitted by the company to the subject ...
Image Source : FILE PHOTO Bharat Biotech applies for emergency approval of coronavirus vaccine -- Covaxin. Hyderabad-based Bharat Biotech, ...
Image Source : PTI Bharat Biotech’s Covid-19 vaccine Covaxin phase-3 trials crosses half-way mark at 13,000 volunteers Bharat Biotech ...
Copyright 2022 © BM Global News. Enjoy our Latest World News.